VREX — Varex Imaging Corporation

Varex Imaging Corporation Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: $229 million, up 11% year-over-year, at the high end of guidance.
• Medical Segment Revenue: $152 million (up 5% YoY).
• Industrial Segment Revenue: $77 million (up 25% YoY), marking the highest quarterly contribution in company history.
• Non-GAAP Gross Margin: 34%, exceeding guidance and up 130 basis points YoY.
• Non-GAAP EPS: $0.37, up from $0.16 YoY.
• Full Year Revenue: $845 million, a 4% increase from FY 2024.
• Full Year Non-GAAP EPS: $0.90, up from $0.52 YoY.
• Cash Position: Ended Q4 with $155 million in cash, down from $213 million YoY due to debt repayment.
• Operating Income: $20 million in Q4, with a full-year operating income of $80 million.

2. Strategic Updates and Business Highlights

• Strong demand observed in the CT market and industrial segments, particularly in security inspection systems.
• Continued investment in R&D, with focus on innovative technologies such as photon counting for CT and radiographic detectors from the new facility in India.
• Significant progress in the cargo inspection systems business, with over $55 million in orders booked in FY 2025.
• Expansion of manufacturing capabilities in India, with the radiographic detector facility ramping up production.
• Positive trends in the industrial segment, driven by increased service revenue contributing to higher gross margins.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected between $200 million and $215 million.
• Non-GAAP EPS Guidance: Anticipated between $0.05 and $0.25.
• Overall, the company expects gradual revenue growth in FY 2026, with medical business growth anticipated, especially outside of China, while modeling flat growth in China.
• Continued focus on strengthening supply chain resilience and expanding product offerings in emerging markets.

4. Bad News, Challenges, or Points of Concern

• Debt Levels: Gross debt outstanding at $370 million, with a net debt leverage ratio of approximately 1.8 times adjusted EBITDA.
• Tariff Impact: Current tariffs are impacting gross margins by 100 to 150 basis points, with ongoing uncertainty regarding U.S.-China trade relations.
• Customer Concentration: Top 10 customers accounted for 52% of revenue, raising concerns about sustainability.
• Geopolitical Risks: Ongoing geopolitical tensions and tariff situations may affect future ordering patterns and market stability.

5. Notable Q&A Insights

• Customer Concentration: Management acknowledged the concentration risk but noted it has been stable over the years.
• China Market Dynamics: While customers in China are projecting stronger orders, the company is modeling flat growth for FY 2026 due to ongoing geopolitical uncertainties.
• Industrial Segment Performance: Higher margins in the industrial segment were attributed to an increased proportion of service revenue, which is typically more profitable.
• R&D Spending: R&D expenses are expected to remain elevated, driven by ongoing investments in growth initiatives, although overall operating expenses are projected to be lower than the previous year.
• Future Product Shipments: The new tube factory in India is still about 12-15 months away from production, which may impact future growth and margin improvements.

This summary encapsulates the key aspects of Varex Imaging Corporation's Q4 2025 earnings call, providing a clear overview of financial performance, strategic direction, and potential challenges ahead.